Palatin Technologies (PTN) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Palatin Technologies (PTN) is Neutral.

The composite score behind that read is -0.15, weighing +0.04 of bullish evidence against -0.39 bearish.

Palatin Technologies last closed at $8.60, -4.55% on the session.

Against the IVW growth benchmark the position is -5.35% over the forecast window.

The read is built from 15 underlying insights — 1 bullish and 14 bearish.

Agreement across those insights is 93%.

20 graded predictions for PTN so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Palatin Technologies in the 9th percentile on return on equity, where 100 is best.

Palatin Technologies is classified under Health Care / Biotechnology, with a market capitalisation of $16.05M.

StockMap tracks Palatin Technologies as the 344th largest of the 381 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 301 Neutral, 63 Moderate Underperform and 17 Moderate Outperform.

On that composite Palatin Technologies ranks 289th of 381 in the group, against a group median of -0.08.

Other Health Care stocks

Palatin Technologies (PTN) — StockMap 2-week forecast & tracked accuracy